
We recap notable headlines from last month in the benign urology space.

We recap notable headlines from last month in the benign urology space.

Kanika Searvance, MD, and Yasin Bhanji, MD, discuss the evolution of BPH care.

Andrew J. Kirsch, MD, FAAP, FACS, outlines current therapies, ranging from behavioral strategies, such as limiting fluids before bedtime, to bedwetting alarms and medications like DDAVP.

Daniel Canter, MD, shares his thoughts on the potential impact of 89Zr-girentuximab for kidney cancer management, if approved.

Joseph Song, MD, discusses his approach to patient selection for the SURE procedure, particularly in comparison to more invasive options such as PCNL.

Joseph Song, MD, details his experience using the CVAC device for SURE procedures.

According to Song, novel aspiration technologies are reshaping not only care delivery, but also long-term treatment outcomes.

David Stanley, MD, FACS, discusses current trends and unmet needs in the treatment of patients with kidney stones.

"I’m hopeful because women in urology are no longer an exception—they’re becoming the norm," says Shaya Taghechian, MD.

As the year comes to a close, we revisit some of this year’s top video content from Urology Times.

As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.

“If you haven't used HYDROS before, or if you're concerned about doing bigger glands or tackling more difficult cases, I think we've shown in our first 35-40,000 cases that Aquablation, the therapy, is a valid therapy,” says Lewis S. Kriteman, MD, FACS.

"I think it's going to help younger or less experienced urologists get more proficient at this procedure faster. That's where the AI is going to come into play," says Lewis S. Kriteman, MD, FACS.

"For [men] to come to the practice and talk about [a sensitive issue] is a big step," says Adity Dutta, MSN, AGACNP-BC.

"Kidney stone treatment is all about access," says Joseph Song, MD.

"Certainly, anybody who is a recurrent stone former, or of a young age when they develop their first stone, they automatically get a 24-hour urine test," says Joseph Song, MD.


"If they have some issues with dexterity, if I feel they're not going to be able to pump the device up adequately, or they don't have a partner that can do it, they're probably not a good candidate for an inflatable device," says Charles Kaplan, MD.

"The success rate is amazing," says Shaya Taghechian, MD, of Bulkamid.


"I feel like there's still a lot of lack of knowledge about the more advanced treatments for men's health; specifically, penile implants," says Charles Kaplan, MD.

"You have to have a passion for it. If you have a passion for it, it's easy to do," says Shaya Taghechian, MD.

"I think that having some clinical guidelines would be very much beneficial for us in midlevel practice," says Adity Dutta, MSN, AGACNP-BC.

"I'd be curious to see a validated study on whether prostate sizes have increased over time. I suspect the answer will be yes," says Joseph Song, MD.

"I can say that I do see a vast number of different types of patient populations," says Adity Dutta, MSN, AGACNP-BC.

"There is a severe lack of treatment when it comes to women's sexual health," says Shaya Taghechian, MD.

"Especially for prostate cancer, some of the sexual side effects, it's tough to talk about that when you're talking to your uncle or your brother who has it," says Joseph Song, MD.

"As most of us know, 1 in 8 couples undergo issues pertaining to fertility, and in about half of those cases, there is a male factor involved, resulting in infertility," says Akash Kapadia, MD.